(Q41313951)

29 September 2017

title

Human IgA monoclonal antibodies specific for a major ragweed pollen antigen (English)

1 reference

29 September 2017

0 references

Sun LK

1

1 reference

29 September 2017

Fung MS

2

1 reference

29 September 2017

Sun WN

3

1 reference

29 September 2017

Sun CR

4

1 reference

29 September 2017

Chang WI

5

1 reference

29 September 2017

Chang TW

6

1 reference

29 September 2017

publication date

1 August 1995

1 reference

29 September 2017

1 reference

29 September 2017

volume

13

1 reference

29 September 2017

issue

8

1 reference

29 September 2017

page(s)

779-786

1 reference

The receptor with high affinity for immunoglobulin E.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

The genetic engineering of monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

21 January 2018

Immunobiology of IgA.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

Molecular mechanisms of immunoglobulin A defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

Aerobiology of pollen and fungal allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

https://api.crossref.org/works/10.1038%2FNBT0895-779

1 reference

7 January 2021

Changes in J chain and mu chain RNA expression as a function of B cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Humanized antibodies: enhancing therapeutic utility through antibody engineering

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Engineering antibodies for therapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Immunoglobulin A monoclonal antibodies protect against Sendai virus

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

ISOLATION AND CHARACTERIZATION OF ALLERGENS FROM RAGWEED POLLEN. II

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

On the structure of polymeric IgM.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Recombinant human IgA expressed in insect cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs

1 reference

https://api.crossref.org/works/10.1038%2FNBT0895-779

7 January 2021

Identifiers

DOI

10.1038/NBT0895-779

1 reference

Dimensions Publication ID

29 September 2017

1027607254

0 references

1 reference